Document is current

Any future updates will be listed below

Favorable outcome of Epstein-Barr virus-associated B-cell lymphoproliferative disorder complicated by immunoglobulin G4-related disease treated with rituximab-based therapy: a case report

Crossref DOI link: https://doi.org/10.1186/s13256-016-1009-1

Published Online: 2016-08-24

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark